✦ LIBER ✦
Long-term safety of fixed-dose combinations: azilsartan medoxomil/chlorthalidone (AZL-M/CLD) vs olmesartan medoxomil/hydrochlorothiazide (OLM/HCTZ) in hypertensive subjects with stage 3 chronic kidney disease
✍ Scribed by Sica, Domenic; Zhao, Lin; Oparil, Suzanne; Kupfer, Stuart; Juhasz, Attila; Hisada, Michie; Huang, Patrick
- Book ID
- 122309222
- Publisher
- Elsevier
- Year
- 2014
- Tongue
- English
- Weight
- 48 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1933-1711
No coin nor oath required. For personal study only.